Search Results 301-310 of 16923 for progesterone

  1. A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer - Mayo Clinic

    ... progesterone only). Women of child bearing potential (WOCBP) must have a negative serum or urine pregnancy test within 5 days prior to randomization. The ...

  2. A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Sunitinib in Patients with Gastrointestinal Stromal Tumour After Progression with Imatinib - Mayo Clinic

    Female partner uses oral contraceptives (combination oestrogen/progesterone pills), injectable progesterone or subdermal implants and a barrier method ...

  3. Women's health Women's health - Mayo Clinic

    Understand women's health issues, including leading health risks, menopause, breast health and more.

  4. Ethinyl estradiol and etonogestrel (vaginal route) - Side effects & dosage - Mayo Clinic

    Etonogestrel and ethinyl estradiol combination is used to prevent pregnancy. It is a flexible birth control vaginal ring that contains two types of hormones, ...

  5. A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects with Early Stage Triple Negative Breast Cancer - Mayo Clinic

    Estrogen Receptor (ER)-, Progesterone Receptor (PR)-, and Human Epidermal Growth Factor Receptor (HER)2-negative (triple-negative) cancer of the breast.

  6. Liver hemangioma - Symptoms & causes - Mayo Clinic

    Also known as hepatic hemangiomas or cavernous hemangiomas, these liver masses are common and are estimated to occur in up to 20% of the population.

  7. A Study of Pembrolizumab (MK-3475) Versus Placebo in Combination with Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer - Mayo Clinic

    ... progesterone receptor), HER2, grade, and PD-L1 status. Note: Adequacy of the ... Has ER–, progesterone receptor positive breast cancer. Participants ...

  8. CYP2C19 Genotype Predictor of Gastric Acid Suppression - Mayo Clinic

    Use of drugs that interfere with CYP2C19 metabolism: Diazepam, phenytoin, amitriptyline, clomipramine, clopidogrel Cyclophosphamide, progesterone, fluoxetine, ...

  9. Mayo Clinic Led Study on Long QT Syndrome Sheds Light on Genetic Testing

    ... . VID-20116660. Home; YouTube - Mayo Clinic Led Study on Long QT Syndrome Sheds Light on Genetic Testing. Double your impact on cancer!

  10. Mayo Clinic

    ... . VID-20428726. Home; Gene Guide Ferber. Double your impact on cancer! Give Now. Make a gift before July 31 and it can be doubled in impact thanks to a ...